Silence Therapeutics PLC

The current institutional shareholding score of Silence Therapeutics PLC is 3.00, ranking 192 out of 385 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 40.59%, representing a quarter-over-quarter increase of 0.85%. The largest institutional shareholder is Steven Cohen, holding a total of 92.78K shares, representing 0.25% of shares outstanding, with 1.34% decrease in holdings.